You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
馬雲捐1億人幣支持研發新肺炎疫苗
阿思達克 01-30 08:48

馬雲公益基金會昨日(29日)宣布,將捐贈1億元人民幣(下同)支持冠狀病毒的疫苗研發。其中,捐贈中國科學院和中國工程院各2,000萬元,用於其所屬專業研究機構當前病毒疫苗專項研發,其餘資金將用於支持國內外各頂尖科研機構和科研人員合作展開對新型冠狀病毒的預防治療工作。

馬雲公益基金會表示,儘管科研人員已經爭分奪秒、全力以赴,但疫苗從研究到最終投入使用絕非一朝一夕的易事,希望在疫苗問世之前疫情就完全得到控制,但人類與病毒的鬥爭是一條漫長的道路,需要更多的耐心和累積,也需要更多的信心與希望。

同時,阿里巴巴(09988.HK)將為公共科研機構免費開放本次病毒疫苗和新藥研發所需的一切AI(人工智能)算力。阿里早前亦設立了10億元醫療物資供應專項基金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account